Research developments in nanobiomaterials for tumor vaccines
Hengheng Dai, Weiwei Kong, Tingting Liu, Xiaoxia Fei · 2026
Read Research developments in nanobiomaterials for tumor vaccines by Hengheng Dai, Weiwei Kong, Tingting Liu, Xiaoxia Fei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13529176.txt.
Description
Dai and colleagues reviewed nanomaterials engineered to deliver tumor vaccines in a 2026 survey of the field. Tumor vaccines train the immune system by giving it tumor antigens, the identifying markers of cancer cells, plus helper substances, so that antigen-presenting cells can activate killer T cells. Conventional vaccines underperform because their antigens are weak and often fail to reach those presenting cells in lymph nodes.
Dai organizes the new delivery materials into four families: polymer-based, fat-based, inorganic, and biomimetic, meaning modeled on natural cells or membranes. Tiny carriers can shield antigens, travel efficiently to lymph nodes, linger there, and be taken up by presenting cells. strengthens the anti-tumor response and may prevent spread and recurrence while reducing off-target effects. The authors map design choices across these families to guide construction of more effective vaccine platforms for clinical use.
Catalog record
| CREATOR | Hengheng Dai, Weiwei Kong, Tingting Liu, Xiaoxia Fei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 37 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |